ASSOCIATION BETWEEN TYPE 2 DIABETES MELLITUS AND COVID-19 SEVERITY: A LITERATURE REVIEW

Objective: Globally, there is a rise in the frequency of type 2 diabetes mellitus and diabetes is severe co-morbidity in COVID-19 patients. We conducted a review and evaluated the already documents reports for the relationship among diabetes and COVID-19. Methods: Full text was retrieved using PubMed database and Google Scholar using the key phrases ‘COVID-19’, ‘SARS-CoV-2’, ‘diabetes’. Results: The review outcome shows that the COVID-19 severity seems to be greater among patients with diabetes as comorbidity. So, strict glycemic control is imperative in patients infected with COVID-19. Conclusions: Thus, world-wide diabetes burden and COVID-19 pandemic must be deliberated as diabetes increases the COVID-19 severity. Established on this, it is precise significant to follow specific treatment protocols and clinical management in COVID-19 patients affected with diabetes to prevent morbidity and mortality

Acute pancreatitis associated with the antibiotic levofloxacin: A rare case report

Key Clinical Message Drug‐induced acute pancreatitis is a potentially ignored diagnosis that must be precisely valued. Drug‐induced acute pancreatitis can be considered the third common cause of acute pancreatitis after ruling out alcohol and gallstones. Levofloxacin belongs to a class of fluoroquinolone antibiotics used for treating various infections. Besides photosensitivity and liver toxicity, levofloxacin can induce acute pancreatitis, although rarely described. We highlight a case of acute pancreatitis in a female induced by levofloxacin. She presented with typical signs and symptoms of acute pancreatitis and had been taking levofloxacin for urinary tract infections for the last 3 days. After ruling out all other possible causes, her clinical picture, laboratory results, and imaging findings confirmed acute pancreatitis induced by levofloxacin